XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   150,598,047      
Beginning balance at Dec. 31, 2021 $ 298,034 $ 16 $ 722,250 $ (1,257) $ (422,975)
Net income (loss) 31,455       31,455
Issuance of common stock pursuant to equity compensation plan (in shares)   5,184      
Share-based compensation 7,049   7,049    
Foreign currency translation adjustments (145)     (145)  
Ending balance (in shares) at Mar. 31, 2022   150,603,231      
Ending balance at Mar. 31, 2022 $ 336,393 $ 16 729,299 (1,402) (391,520)
Beginning balance (in shares) at Dec. 31, 2022 132,214,695 132,214,695      
Beginning balance at Dec. 31, 2022 $ 164,335 $ 14 550,320 (4,530) (381,469)
Net income (loss) (22,285)       (22,285)
Issuance of common stock pursuant to equity compensation plan (in shares)   473,049      
Shares withheld for tax withholdings on vested stock awards (in shares)   (170,415)      
Shares withheld for tax withholdings on vested stock awards (2,195)   (2,195)    
Issuance of Common Stock relating to employee stock purchase plan 2,034   2,034    
Share-based compensation 3,577   3,577    
Common Stock relating to acquisition (in shares)   109,625      
Common Stock relating to asset acquisition 1,310   1,310    
Foreign currency translation adjustments $ 888     888  
Ending balance (in shares) at Mar. 31, 2023 132,626,954 132,626,954      
Ending balance at Mar. 31, 2023 $ 147,664 $ 14 $ 555,046 $ (3,642) $ (403,754)